vs
CareDx, Inc.（CDNA）与null（SWIM）财务数据对比。点击上方公司名可切换其他公司
CareDx, Inc.的季度营收约是null的1.2倍（$117.7M vs $100.0M），CareDx, Inc.净利率更高（2.4% vs -7.0%，领先9.4%），CareDx, Inc.同比增速更快（39.0% vs 14.5%），null自由现金流更多（$14.1M vs $514.0K），过去两年CareDx, Inc.的营收复合增速更高（12.9% vs -4.9%）
CareDx是一家专注于器官移植领域的精准医疗企业，核心产品包括移植排斥反应监测诊断试剂、数字健康管理工具及配套临床服务，面向北美和欧洲市场的医疗机构及移植患者，助力提升术后患者生存质量。
该企业是一家源自美国的跨国律师事务所，1934年创立于加利福尼亚州洛杉矶，在诉讼业务、公司法务以及监管合规法律领域拥有深厚的行业积累与知名度，是全球颇具影响力的综合性律所之一。
CDNA vs SWIM — 直观对比
营收规模更大
CDNA
是对方的1.2倍
$100.0M
营收增速更快
CDNA
高出24.5%
14.5%
净利率更高
CDNA
高出9.4%
-7.0%
自由现金流更多
SWIM
多$13.6M
$514.0K
两年增速更快
CDNA
近两年复合增速
-4.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $117.7M | $100.0M |
| 净利润 | $2.8M | $-7.0M |
| 毛利率 | — | 28.0% |
| 营业利润率 | 1.0% | -10.7% |
| 净利率 | 2.4% | -7.0% |
| 营收同比 | 39.0% | 14.5% |
| 净利润同比 | — | 76.0% |
| 每股收益（稀释后） | $0.05 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDNASWIM
| Q1 26 | $117.7M | — | ||
| Q4 25 | $108.4M | $100.0M | ||
| Q3 25 | $100.1M | $161.9M | ||
| Q2 25 | $86.7M | $172.6M | ||
| Q1 25 | $84.7M | $111.4M | ||
| Q4 24 | $86.6M | $87.3M | ||
| Q3 24 | $82.9M | $150.5M | ||
| Q2 24 | $92.3M | $160.1M |
净利润CDNASWIM
| Q1 26 | $2.8M | — | ||
| Q4 25 | $-4.1M | $-7.0M | ||
| Q3 25 | $1.7M | $8.1M | ||
| Q2 25 | $-8.6M | $16.0M | ||
| Q1 25 | $-10.4M | $-6.0M | ||
| Q4 24 | $87.7M | $-29.2M | ||
| Q3 24 | $-10.6M | $5.9M | ||
| Q2 24 | $-4.6M | $13.3M |
毛利率CDNASWIM
| Q1 26 | — | — | ||
| Q4 25 | — | 28.0% | ||
| Q3 25 | — | 35.4% | ||
| Q2 25 | — | 37.1% | ||
| Q1 25 | — | 29.5% | ||
| Q4 24 | — | 24.6% | ||
| Q3 24 | — | 32.4% | ||
| Q2 24 | — | 33.1% |
营业利润率CDNASWIM
| Q1 26 | 1.0% | — | ||
| Q4 25 | -5.6% | -10.7% | ||
| Q3 25 | -0.2% | 13.3% | ||
| Q2 25 | -12.8% | 14.3% | ||
| Q1 25 | -15.8% | -4.4% | ||
| Q4 24 | 97.5% | -14.9% | ||
| Q3 24 | -16.6% | 8.9% | ||
| Q2 24 | -7.9% | 12.5% |
净利率CDNASWIM
| Q1 26 | 2.4% | — | ||
| Q4 25 | -3.8% | -7.0% | ||
| Q3 25 | 1.7% | 5.0% | ||
| Q2 25 | -9.9% | 9.3% | ||
| Q1 25 | -12.2% | -5.4% | ||
| Q4 24 | 101.3% | -33.4% | ||
| Q3 24 | -12.8% | 3.9% | ||
| Q2 24 | -5.0% | 8.3% |
每股收益（稀释后）CDNASWIM
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-0.08 | $-0.06 | ||
| Q3 25 | $0.03 | $0.07 | ||
| Q2 25 | $-0.16 | $0.13 | ||
| Q1 25 | $-0.19 | $-0.05 | ||
| Q4 24 | $1.60 | $-0.24 | ||
| Q3 24 | $-0.20 | $0.05 | ||
| Q2 24 | $-0.09 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.9M | — |
| 总债务越低越好 | — | $279.8M |
| 股东权益账面价值 | — | $405.9M |
| 总资产 | $411.1M | $823.2M |
| 负债/权益比越低杠杆越低 | — | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资CDNASWIM
| Q1 26 | $77.9M | — | ||
| Q4 25 | $177.2M | — | ||
| Q3 25 | $194.2M | — | ||
| Q2 25 | $186.3M | — | ||
| Q1 25 | $230.9M | — | ||
| Q4 24 | $260.7M | — | ||
| Q3 24 | $240.9M | — | ||
| Q2 24 | $228.9M | — |
总债务CDNASWIM
| Q1 26 | — | — | ||
| Q4 25 | — | $279.8M | ||
| Q3 25 | — | $281.1M | ||
| Q2 25 | — | $281.5M | ||
| Q1 25 | — | $306.9M | ||
| Q4 24 | — | $281.5M | ||
| Q3 24 | $0 | $282.8M | ||
| Q2 24 | $0 | $282.4M |
股东权益CDNASWIM
| Q1 26 | — | — | ||
| Q4 25 | $303.1M | $405.9M | ||
| Q3 25 | $311.1M | $408.4M | ||
| Q2 25 | $327.4M | $398.4M | ||
| Q1 25 | $379.3M | $381.1M | ||
| Q4 24 | $378.4M | $387.2M | ||
| Q3 24 | $273.2M | $416.6M | ||
| Q2 24 | $264.7M | $408.1M |
总资产CDNASWIM
| Q1 26 | $411.1M | — | ||
| Q4 25 | $413.2M | $823.2M | ||
| Q3 25 | $432.3M | $844.4M | ||
| Q2 25 | $444.3M | $822.1M | ||
| Q1 25 | $489.6M | $824.6M | ||
| Q4 24 | $491.1M | $794.2M | ||
| Q3 24 | $477.0M | $853.4M | ||
| Q2 24 | $466.8M | $830.0M |
负债/权益比CDNASWIM
| Q1 26 | — | — | ||
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 0.81× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | 0.00× | 0.68× | ||
| Q2 24 | 0.00× | 0.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.3M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $514.0K | $14.1M |
| 自由现金流率自由现金流/营收 | 0.4% | 14.1% |
| 资本支出强度资本支出/营收 | — | 9.2% |
| 现金转化率经营现金流/净利润 | 1.54× | — |
| 过去12个月自由现金流最近4个季度 | — | $38.0M |
8季度趋势，按日历期对齐
经营现金流CDNASWIM
| Q1 26 | $4.3M | — | ||
| Q4 25 | $21.4M | $23.3M | ||
| Q3 25 | $37.4M | $51.0M | ||
| Q2 25 | $9.9M | $36.0M | ||
| Q1 25 | $-26.6M | $-46.9M | ||
| Q4 24 | $21.9M | $6.2M | ||
| Q3 24 | $12.5M | $37.2M | ||
| Q2 24 | $18.9M | $52.4M |
自由现金流CDNASWIM
| Q1 26 | $514.0K | — | ||
| Q4 25 | — | $14.1M | ||
| Q3 25 | — | $45.2M | ||
| Q2 25 | — | $29.1M | ||
| Q1 25 | — | $-50.3M | ||
| Q4 24 | — | $-98.0K | ||
| Q3 24 | — | $33.2M | ||
| Q2 24 | — | $47.9M |
自由现金流率CDNASWIM
| Q1 26 | 0.4% | — | ||
| Q4 25 | — | 14.1% | ||
| Q3 25 | — | 27.9% | ||
| Q2 25 | — | 16.8% | ||
| Q1 25 | — | -45.2% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | — | 22.1% | ||
| Q2 24 | — | 29.9% |
资本支出强度CDNASWIM
| Q1 26 | — | — | ||
| Q4 25 | — | 9.2% | ||
| Q3 25 | — | 3.6% | ||
| Q2 25 | — | 4.0% | ||
| Q1 25 | — | 3.1% | ||
| Q4 24 | — | 7.2% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 2.8% |
现金转化率CDNASWIM
| Q1 26 | 1.54× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 22.30× | 6.29× | ||
| Q2 25 | — | 2.25× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.25× | — | ||
| Q3 24 | — | 6.32× | ||
| Q2 24 | — | 3.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDNA
| Financial Results Total | $85.0M | 72% |
| Patient and digital solutions revenue | $16.0M | 14% |
| Product revenue | $10.3M | 9% |
| Other | $6.4M | 5% |
SWIM
| In Ground Swimming Pools | $50.2M | 50% |
| Covers | $37.0M | 37% |
| Liners | $12.7M | 13% |
